Avantor, Inc. (NYSE:AVTR) Given Consensus Recommendation of “Hold” by Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have earned a consensus rating of “Hold” from the sixteen analysts that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $11.8333.

AVTR has been the subject of several analyst reports. Zacks Research cut shares of Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. Morgan Stanley set a $10.00 target price on Avantor in a research report on Friday, February 13th. Stifel Nicolaus set a $10.00 target price on Avantor in a research note on Thursday, February 12th. Citigroup decreased their price target on Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research note on Thursday, February 12th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $12.00 price objective (down previously from $14.00) on shares of Avantor in a report on Thursday, October 30th.

Avantor Stock Down 1.6%

Avantor stock opened at $8.89 on Tuesday. Avantor has a twelve month low of $8.83 and a twelve month high of $18.02. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The stock has a 50 day moving average of $11.14 and a two-hundred day moving average of $12.09. The stock has a market capitalization of $6.06 billion, a price-to-earnings ratio of -11.40, a PEG ratio of 3.56 and a beta of 0.94.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. Avantor’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period last year, the firm posted $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, research analysts expect that Avantor will post 1.06 earnings per share for the current year.

Insider Transactions at Avantor

In related news, Director Sanjeev K. Mehra acquired 350,000 shares of the firm’s stock in a transaction that occurred on Friday, December 5th. The shares were purchased at an average price of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the acquisition, the director owned 350,000 shares in the company, valued at approximately $3,881,500. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gregory L. Summe bought 100,000 shares of the stock in a transaction on Thursday, February 12th. The shares were bought at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the transaction, the director directly owned 400,000 shares of the company’s stock, valued at $3,760,000. This trade represents a 33.33% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 500,000 shares of company stock valued at $5,279,500 in the last ninety days. 1.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Avantor

Several institutional investors have recently modified their holdings of AVTR. Wellington Management Group LLP purchased a new position in Avantor in the 4th quarter valued at approximately $268,584,000. Greenhaven Associates Inc. acquired a new stake in Avantor in the third quarter valued at $228,528,000. Dodge & Cox increased its position in shares of Avantor by 17.1% in the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock valued at $1,580,655,000 after buying an additional 17,170,761 shares in the last quarter. London Co. of Virginia purchased a new position in shares of Avantor in the third quarter valued at $159,669,000. Finally, Morgan Stanley raised its stake in shares of Avantor by 179.4% during the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock worth $200,188,000 after buying an additional 11,216,565 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.